Mekahli, D., Liebau, M. C., Cadnapaphornchai, M. A., Goldstein, S. L., Greenbaum, L., Litwin, M., . . . Guay-Woodford, L. M. (2023). Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology, 24, . https://doi.org/10.1186/s12882-023-03072-x
Chicago Style (17th ed.) CitationMekahli, Djalila, Max C. Liebau, Melissa A. Cadnapaphornchai, Stuart L. Goldstein, Larry Greenbaum, Mieczysław Litwin, Tomas Seeman, Franz Schaefer, and Lisa M. Guay-Woodford. "Design of Two Ongoing Clinical Trials of Tolvaptan in the Treatment of Pediatric Patients with Autosomal Recessive Polycystic Kidney Disease." BMC Nephrology 24 (2023). https://doi.org/10.1186/s12882-023-03072-x.
MLA (9th ed.) CitationMekahli, Djalila, et al. "Design of Two Ongoing Clinical Trials of Tolvaptan in the Treatment of Pediatric Patients with Autosomal Recessive Polycystic Kidney Disease." BMC Nephrology, vol. 24, 2023, https://doi.org/10.1186/s12882-023-03072-x.